NTP awards 10-year contract to Batelle
Toxicology research to be conducted by Batelle will consist of various studies of compounds that can be inhaled or those that can contaminate water sources.
“These studies build upon the considerable experience Battelle has supporting the NTP over the past decades” vice president of business development for Battelle’s Life Sciences Research David Moore said. “Toxicology research is an important segment of our life science business, which also includes pre-clinical studies supporting FDA licensure of drugs as well as world-class capabilities for biological containment research supporting new drug and vaccine development.”
Compounds specifically named in the announcement include alpha-pinene, sulfolane and various vanandium based compounds. The NTP reports that over 80,000 chemical compounds are registered for use in the U.S. Approximately 2,000 of these introduced for everyday food and other personal care products without full knowledge of the health and environmental impact of their use. Both the effect and what levels of exposure would be hazardous to health are needed in order to protect the public.
The company, which focuses on research and development in a number of scientific fields, will present data from its initial research to the Society of Toxicology at the ToxExpo March 22-26 in San Diego.